Investigating the Uptake of Hypofractionation for Breast and Prostate Cancer in Sub-Saharan Africa: A Qualitative Study of Physician and Medical Physicist Perspectives
HF is regarded as a valuable tool for breast and prostate cancer in SSA, and breast HF is widely used. Attention to the use of 3-dimensional conformal radiation therapy with HF, long-term toxicity data in African populations, and training sessions may facilitate further use of HF for prostate cancer.
Authors
- Surbhi Grover (ORCID: https://orcid.org/0000-0001-7443-5937)
- Katharine A. Rendle (ORCID: https://orcid.org/0000-0002-7761-8728)
- Wilfred Ngwa (ORCID: https://orcid.org/0000-0001-8317-6850)
- Rohini Bhatia (ORCID: https://orcid.org/0000-0002-1444-7378)
- Suzanne M. Grieb (ORCID: https://orcid.org/0000-0001-9971-4115)
Institutions
- Johns Hopkins University (US)
- Emory University (US)
- University of Botswana (BW)
- Johns Hopkins Medicine (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Advances in Radiation Oncology
- Published
- 2024-11-15
- DOI
- https://doi.org/10.1016/j.adro.2024.101683
- Citations
- 1
- Primary Topic
- Advances in Oncology and Radiotherapy
- Type
- article
- Field-Weighted Citation Impact
- 0.40
Funders
- Breast Cancer Research Foundation
- University of Texas MD Anderson Cancer Center